Synthetic biology and machine learning for human cell stress responses
Our proprietary synthetic biology technology allows us to virtually activate cellular stress responses, discover drugs targeting stressed cells, and rapidly identify drug targets. We have also developed next-generation deep learning approaches to identifying small molecules that will accelerate our discovery efforts.
Cellular stress responses contribute to diseases including neurodegeneration, cancer, diabetes, osteoarthritis, and other age-associated diseases. Targeting these stress responses with small molecule therapeutics is disease-modifying and will help to mediate healthy aging.
Visit website: https://integratebio.co/
Integrated Biosciences News
AI-driven breakthrough in senolytic drug discovery
Lifespan.io (LEAF) - 04-May-2023
Machine learning successfully identifies promising senolytic compounds to target ageing and age-related diseasesRead more...